Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important?
Saved in:
| Title: | Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important? |
|---|---|
| Authors: | Vitale P; Oncology Operative Unit, Hospital of Frattamaggiore, Frattamaggiore, Italy., De Falco V; Oncology Operative Unit, Hospital of Frattamaggiore, Frattamaggiore, Italy., Addeo R; Oncology Operative Unit, Hospital of Frattamaggiore, Frattamaggiore, Italy. |
| Source: | Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2024 Jul; Vol. 24 (7), pp. 481-484. Date of Electronic Publication: 2024 May 13. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38733083 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vitale+P%22">Vitale P</searchLink>; Oncology Operative Unit, Hospital of Frattamaggiore, Frattamaggiore, Italy.<br /><searchLink fieldCode="AU" term="%22De+Falco+V%22">De Falco V</searchLink>; Oncology Operative Unit, Hospital of Frattamaggiore, Frattamaggiore, Italy.<br /><searchLink fieldCode="AU" term="%22Addeo+R%22">Addeo R</searchLink>; Oncology Operative Unit, Hospital of Frattamaggiore, Frattamaggiore, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101123358%22">Expert review of anticancer therapy</searchLink> [Expert Rev Anticancer Ther] 2024 Jul; Vol. 24 (7), pp. 481-484. <i>Date of Electronic Publication: </i>2024 May 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Editorial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101123358 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-8328 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214737140%22">14737140 </searchLink><i>NLM ISO Abbreviation: </i>Expert Rev Anticancer Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38733083 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/14737140.2024.2354772 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 481 Titles: – TitleFull: Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vitale P – PersonEntity: Name: NameFull: De Falco V – PersonEntity: Name: NameFull: Addeo R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2024 Jul Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1744-8328 Numbering: – Type: volume Value: 24 – Type: issue Value: 7 Titles: – TitleFull: Expert review of anticancer therapy Type: main |
| ResultId | 1 |
